This viewpoint is reinforced by a paper that showed improvements in obesity and diabetes when levels of acyl ghrelin were reduced, levels of Leap2 were increased, or GHSR activity was blocked (173). This evidence concerns the gene LEAP2 and obesity due to melanocortin 4 receptor deficiency.